(Q37014122)

17 August 2017

1 reference

title

Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases (English)

1 reference

stem cell transplantation

17 August 2017

main subject

1 reference

Satwani P

1

1 reference

17 August 2017

Cooper N

2

1 reference

17 August 2017

Rao K

3

1 reference

17 August 2017

Veys P

4

1 reference

17 August 2017

Amrolia P

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

26 November 2007

1 reference

Bone Marrow Transplantation

17 August 2017

published in

1 reference

17 August 2017

volume

41

1 reference

17 August 2017

issue

2

1 reference

17 August 2017

page(s)

173-182

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705923

17 August 2017

exact match

0 references

cites work

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Graft-versus-leukemia reactions in allogeneic chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Is Pneumocystis carinii pneumonia after stem cell transplantations a contagious disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Bone marrow transplantation without myeloablation for sickle cell disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Stem cell transplantation for children with Glanzmann thrombasthenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705923

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705923

1 reference

17 August 2017

1 reference